- This event has passed.
THE INTESTINAL MICROBIOME IN HEALTH, DISEASE & AGEING
October 16 - October 17$550
THE INTESTINAL MICROBIOME IN HEALTH, DISEASE & AGEING
- The role of the gut microbiota in ageing and the connection between the microbiota and the health of vital organs
- The connection with the intestinal microbiome and musculoskeletal disorders.
- The use of probiotics in the prevention and treatment of diarrhoea induced by either radiation or chemotherapy.
- The connection between non-alcoholic fatty liver disease and modulating the gastrointestinal microbiome as a key factor in the treatment and management of this disorder
- Probiotic supplementation as a key intervention in the prevention and management of diabetes
- Clinical options for treating metabolic syndrome and achieving long-lasting weight loss.
- Disturbances to the gut microbiota may be related to infertility in males.
- The role of the gut in mood disorders.
This activity is eligible for points as a Group 1 CPD Activity, by the Pharmacy Board of Australia. This activity may be converted to a Group 2 CPD Activity and will provide Pharmacists with 29 CPD Points after all the requirements are fulfilled and the participants knowledge and skills can be demonstrated through the successful completion of an assessment.
Medical practitioners can self record attendance at this workshop as Category 2 QI&CPD Points.
This activity is also eligible for CPD points with the following associations: ANTA, ATMS, ANPA.
09:00 – 09:30 | The overarching role of the gut microbiome in ageing | Professor Luis Vitetta
09:30 – 10:00 | The Effect of a Multi-Species Probiotic Formulation to Prevent Chemotherapy Induced Diarrhoea by Rescuing Gastrointestinal Mucositis/Dysbiosis. An efficacy / tolerability probing study | Michael Thomsen
10:00 – 10.30 | Intestinal Dysbiosis and Mood | Dr Matthew Bambling
10:30 – 11:00 | MORNING TEA BREAK
11:00 – 11:30 | The Effect of a Multi-strain Probiotic on Metabolic Biomarkers in Pre-diabetic Adults | Talia Palacios
11:30 – 12:00 | The Effect of a Multi-Species Probiotic Formulation to Manage Non-Alcoholic Fatty Liver Disease By Modulating Gastrointestinal Microbiome Disturbances | Emma Saltzman
12:00 – 12:30 | Q & A Discussion
12:30 – 13:30 | LUNCH BREAK
13:30 – 14:00 | Subfertility/infertility in Australian men attending fertility clinics, their allergic status, and the relationship to their gastrointestinal microbiome | Dr Giselle Cooke
14:00 – 14:30 | How to treat the metabolic syndrome and achieve weight loss | Dr Peter Tunbridge
14:30 – 15:00 | The intestinal microbiome and musculoskeletal disease | Professor Luis Vitetta
15:00 – 15:30 | The administration of Nanocelle Vitamin D3 and B12 | TBA
15:30 – 16:00 | AFTERNOON TEA BREAK
16:00 – 17:00 | Panel Session | Bringing it all together | Clinical Case Studies | Open forum:
17:00 | CLOSE
Professor Luis Vitetta
BSc(Hons), PhD, GradDip IntegrMed, GradDip NutrEnvironMed
Luis Vitetta is currently Adjunct Professor at the University of Sydney, Sydney Medical School and Director of Medical Research at MedLab in Sydney
MSc, ND, DBM
Michael is a PhD scholar at the University of Sydney, and is affiliated with Medlab Clinical. He has a Master’s degree in Applied Science and has been practicing as a naturopath and herbalist for 30 years, specialising in cancer support utilising nutritional and herbal medicines and hyperthermia devices. Michael is researching radiochemotherapy-induced mucositis, intestinal dysbiosis and the role of probiotics in preventing and or reducing chemotherapy/radiotherapy-induced diarrhoea in patients diagnosed with abdominal or pelvic tumours.
MBBS, Dip Acup, DBM.
Giselle trained as a medical practitioner at The University of NSW in the 1970’s, an era when medicine became more progressive, community-based and patient-centric.She discovered the treasure trove of alternative medicines during her undergraduate years, exploring and studying traditional Chinese medicine at night school whilst developing skills and knowledge in medicine and surgery.
Matthew is a clinical psychologist, who gained his PhD at the University of Queensland where he holds an academic position at the School of Medicine. He coordinates the postgraduate mental health programs.Matthew has published extensively in the area of evidence based treatments. He has a strong track record in conducting clinical treatment trials and has made internationally recognised contributions to psychological treatments for major depressive disorder and novel online treatment delivery modalities.
Dr Peter Tunbridge is a General Practitioner who has a special interest in natural hormone replacement and metabolic medicine. Before he studied Medicine he graduated from the University of Adelaide in Science and worked as a scientist at the Institute of Medical and Veterinary Science.
Talia is a PhD candidate at the University of Sydney. She holds a Bachelor degree in Science, Bachelor degree in Psychology and a Master degree in Dietetics from the University of San Francisco de Quito (Ecuador). Talia has 10 years of experience in clinical practice.
B Nutri & Dietetics (Hons)
Emma is a PhD scholar at the University of Sydney and is affiliated with Medlab Clinical. She holds a Honours degree in Nutrition and Dietetics from Monash University (Victoria, Australia) and is an Accredited Practising Dietitian. Emma’s current research area of interest is the relationship between the dysbiosis of the microbiome and obesity-related disorders. Her PhD project focuses on non-alcoholic fatty liver disease, intestinal dysbiosis and the role of probiotics as a therapeutic agent in patients with early stage non-alcoholic fatty liver disease.
- October 16
- October 17
- Event Category:
- Partner Events
- Event Tags:
- B12, chemotherapy, Diabetes, diarrhoea, gut microbiota, intestinal microbiome, metabolic syndrome, musculoskeletal disorders, probiotics, Professor Luis Vitetta, Vitamin D3